Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Our priority has always been to raise awareness of available treatments for VCFs and to refine our innovative technology in partnership with physicians and patients.
VCFs are associated with a downward spiral of complications, including decreased mobility, pain, and function.1 Clinical evidence has shown that BKP has offered important clinical benefits compared to non-surgical management, including pain relief, reduced opioid use, and improved quality of life.2-6
Kyphon balloon kyphoplasty is celebrating 20 years of reliability, partnership, and confidence. Here are summaries of five studies sponsored by Medtronic that test the efficacy of Kyphon balloon kyphoplasty:
Balloon Kyphoplasty is a minimally invasive procedure for the treatment of pathological fractures of the vertebral body due to osteoporosis, cancer, or benign lesion. Cancer includes multiple myeloma and metastatic lesions, including those arising from breast or lung cancer, or lymphoma. Benign lesions include hemangioma and giant cell tumor.
The overall complication rate with the procedure has been demonstrated to be low. Risks of acrylic bone cements include cement leakage, which may cause tissue damage, nerve or circulatory problems, and other serious adverse events, such as: cardiac arrest, cerebrovascular accident, myocardial infarction, pulmonary embolism, cardiac embolism.
For complete information regarding indications for use, contraindications, warnings, precautions, adverse events, and methods of use, please reference the devices’ Instructions for Use included with the product.
Beall DP, Chambers MR, Thomas S, et al. Prospective and multicenter evaluation of outcomes for quality of life and activities of daily living for balloon kyphoplasty in the treatment of vertebral compression fractures: the EVOLVE trial. Neurosurgery. 2019;84:169-178.
The EVOLVE study investigated 12-month disability, quality of life, and safety outcomes of VCF patients seen in routine clinical practice. This large, prospective, clinical study demonstrated that kyphoplasty (n = 350) resulted in a statistically significant (p < 0.001) reduction in pain and disability, and improved function and quality of life, across all time points — which matters to patients.
The study also reported that within 1 to 3 months after BKP treatment, patients had outcomes that were close to those estimated prior to the fracture event — and outcomes were statistically significant (p < 0.001) and sustained through 12 months.
Single-arm study with no control comparison; 25 percent loss to follow-up at 12 months. Heterogeneity was introduced by including both osteoporotic and neoplastic fractures, but vast majority of subjects (98 percent) had osteoporosis.
Dohm M, Black CM, Dacre A, Tillman JB, Fueredi G, KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR Am J Neuroradiol. 2014;35:2227-2236.
This randomized trial compared the efficacy of balloon kyphoplasty (n = 191) with vertebroplasty (n = 190) in patients with osteoporosis and one to three acute fractures. In comparing kyphoplasty and vertebroplasty, the study found:
Lack of patient blinding, substantial loss to follow-up, and early termination (404 enrolled out of 1,234 patient enrollment goal), which resulted in lack of statistical power for the primary endpoint.
Van Meirhaeghe J, Bastian L, Boonen S, et al. A randomized trial of balloon kyphoplasty and nonsurgical management for treating acute vertebral compression fractures: vertebral body kyphosis correction and surgical parameters. Spine. 2013;38:971-983.
A multi-center randomized controlled trial compared the safety of BKP (n = 149) with non surgical management (n = 151) during 24 months in patients with painful VCFs from osteoporosis. The study found that patients with BKP:
Berenson J, Pflugmacher R, Jarzem P, et al. Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. Lancet Oncology. 2011;12:225-235.
This randomized, controlled trial at 22 sites in North America, Europe, and Australia assessed the efficacy and safety of balloon kyphoplasty (n = 70) compared with non-surgical management (n = 64) for patients with cancer who had painful VCFs. For BKP patients, the study showed:
Improved Function BKP: baseline 17.6; 1 month 9.1 (within group change p < 0.0001); NSM: baseline 18.2; 1 month 18 (within group change p=0.83). Between group differences at 1 month p < 0.0001.
Boonen S, Van Meirhaeghe J, Bastian L, et al. Balloon kyphoplasty for the treatment of acute vertebral compression fractures: 2-year results from a randomized trial. J Bone Miner Res. 2011;26:1627-1637.
A Medtronic-sponsored, randomized controlled trial comparing Kyphon Balloon Kyphoplasty (n = 149) to non surgical management (n = 151)* found that people with spinal fractures with osteoporosis treated with Kyphon Balloon Kyphoplasty had:
Better clinical results compared to non-surgical management:
Comparable safety results vs. NSM:
TITLE |
Beall DP, Chambers MR, Thomas S, et al. Prospective and multicenter evaluation of outcomes for quality of life and activities of daily living for balloon kyphoplasty in the treatment of vertebral compression fractures: the EVOLVE trial. Neurosurgery. 2019;84:169-178. |
---|---|
STUDY DESIGN |
|
ENDPOINTS |
Four co-primary endpoints: Numerical Rating Scale back pain (NRS), Oswestry Disability Index (ODI), Short Form 36-question Physical Component Summary (SF-36v2 PCS), EuroQol-5-Domain (EQ-5D) were evaluated for statistically significant improvement 3 months after kyphoplasty. |
RESULTS |
|
LIMITATIONS |
Single-arm study with no control comparison; 25 percent loss to follow-up at 12 months. Heterogeneity was introduced by including both osteoporotic and neoplastic fractures, but vast majority of subjects (98 percent) had osteoporosis. |
TITLE |
Dohm M, Black CM, Dacre A, Tillman JB, Fueredi G, KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR Am J Neuroradiol. 2014;35:2227-2236. |
---|---|
STUDY DESIGN |
|
ENDPOINTS |
|
RESULTS |
|
LIMITATIONS |
Lack of patient blinding, substantial loss to follow-up and early termination (404 enrolled out of 1,234 patient enrolment goal), which resulted in lack of statistical power for the primary endpoint. |
TITLE |
Van Meirhaeghe J, Bastian L, Boonen S, et al. A randomized trial of balloon kyphoplasty and nonsurgical management for treating acute vertebral compression fractures: vertebral body kyphosis correction and surgical parameters. Spine. 2013;38:971-983. |
---|---|
STUDY DESIGN |
|
ENDPOINTS |
|
RESULTS |
Mean improvement across all visits through 24-months was better in BKP vs. NSM
|
LIMITATIONS |
|
TITLE |
Berenson J, Pflugmacher R, Jarzem P, et al. Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. Lancet Oncology. 2011;12:225-235. |
---|---|
STUDY DESIGN |
|
ENDPOINTS |
|
RESULTS |
|
LIMITATIONS |
|
TITLE |
Boonen S, Van Meirhaeghe J, Bastian L, et al. Balloon kyphoplasty for the treatment of acute vertebral compression fractures: 2-year results from a randomized trial. J Bone Miner Res. 2011;26:1627-1637. |
---|---|
STUDY DESIGN |
|
ENDPOINTS |
|
RESULTS |
|
LIMITATIONS |
|
Tillman J, Shabe P, Rose M, Elson P, Wülfert E, Ashraf T. Fracture Reduction Evaluation Study 24-month final clinical study report, August 27, 2010. Medtronic Spinal and Biologics Europe BVBA. fractures (VCFs) due to osteoporosis. Am J Neuroradiol. 2014;35(12):2227-2236.
Beall DP, Chambers MR, Thomas S, et al. Prospective and multicenter evaluation of outcomes for quality of life and activities of daily living for balloon kyphoplasty in the treatment of vertebral compression fractures: the EVOLVE trial. Neurosurgery. 2019;84:169-178.
Dohm M, Black CM, Dacre A, Tillman JB, Fueredi G, KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR Am J Neuroradiol. 2014;35:2227-2236.
Van Meirhaeghe J, Bastian L, Boonen S, et al. A randomized trial of balloon kyphoplasty and nonsurgical management for treating acute vertebral compression fractures: vertebral body kyphosis correction and surgical parameters. Spine. 2013;38:971-983
Berenson J, Pflugmacher R, Jarzem P, et al. Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. Lancet Oncology. 2011;12:225-235.
Boonen S, Van Meirhaeghe J, Bastian L, et al. Balloon kyphoplasty for the treatment of acute vertebral compression fractures: 2-year results from a randomized trial. J Bone Miner Res. 2011;26:1627-1637.